Clinical Trials Browser

Phase 1/2 × Enrolling by invitation × Breast × Clear all

NCT06603987 2025-11-19

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Phase 1/2 Enrolling by invitation

BreastGastrointestinalOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Neurofibrosarcoma

NCT06768268 2025-04-16

ICGMV

Phase 1/2 Enrolling by invitation

Breast Neoplasms

NCT03328026 2025-02-04

Combination Study of SV-BR-1-GM With Retifanlimab

Phase 1/2 Enrolling by invitation

Breast Neoplasms